3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Uveal Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lichen Planus, Oral
2
Stomach Neoplasms
1
Retinal Diseases
1
Recurrence
1
Radiodermatitis
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pain
1
Neuroma, Acoustic
1
Mycosis Fungoides
1
Melanoma
1
Macular Degeneration
1
Lymphomatoid Papulosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leiomyoma
1
Glioblastoma
1
Fibroma
1
Exanthema
1
Esophageal Stenosis Acquired
1
Dupuytren Contracture
1
Disease
1
Dermatitis, Contact
1
Choroid Diseases
1
Chalazion
1
Castration Resistant Prostate Cancer
1
Interventions
Surveys and Questionnaires
15
Acupuncture Therapy
15
Fentanyl
14
Morphine
13
Acetaminophen
13
Analgesia
12
Lidocaine
11
Ketamine
11
Bupivacaine
11
Methadone
10
Therapeutics
9
Ropivacaine
9
Psychiatric Rehabilitation
9
Oxycodone
9
Hydromorphone
7
Saline Solution
6
Radiotherapy
6
Music Therapy
6
Early Intervention, Educational
6
Zoledronic Acid
5
Yoga
5
Water
5
Methods
5
Control Groups
5
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Physical Therapy Modalities
4
Massage
4
Ketorolac
4
Exercise
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain
×
Triamcinolone Acetonide
×
Clear all
NCT02025023
2020-02-06
CTS
University of Washington
Phase 3
Recruiting
120 enrolled